Recent literature highlights nerve growth factor (NGF) as a key neurotrophin potentially serving as a promising diagnostic biomarker for Alzheimer’s disease [5], frontotemporal dementia [6], malignancies [7] and overactive bladder syndrome [8]. This evidence concerns the gene NGF and Alzheimer disease.